Amphastar Pharmaceuticals, Inc. Quarterly Goodwill in USD from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Amphastar Pharmaceuticals, Inc. quarterly Goodwill history and growth rate from Q4 2012 to Q3 2024.
  • Amphastar Pharmaceuticals, Inc. Goodwill for the quarter ending September 30, 2024 was $3.26M, a 5.3% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.26M +$164K +5.3% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $3.13M -$36K -1.14% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $3.15M -$23K -0.72% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $3.22M +$90K +2.88% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $3.09M +$206K +7.14% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $3.17M +$111K +3.64% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $3.18M -$81K -2.49% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $3.13M -$187K -5.64% Dec 31, 2022 10-Q 2024-11-07
Q3 2022 $2.89M -$500K -14.8% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $3.05M -$786K -20.5% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $3.26M -$537K -14.2% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $3.31M -$627K -15.9% Dec 31, 2021 10-K 2024-02-29
Q3 2021 $3.39M -$387K -10.3% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $3.84M +$207K +5.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $3.79M +$222K +6.22% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $3.94M +$306K +8.42% Dec 31, 2020 10-K 2023-03-01
Q3 2020 $3.77M -$13K -0.34% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $3.63M -$297K -7.56% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $3.57M -$324K -8.32% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $3.63M -$317K -8.02% Dec 31, 2019 10-K 2022-03-11
Q3 2019 $3.79M -$211K -5.28% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $3.93M -$431K -9.88% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $3.9M -$688K -15% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $3.95M -$510K -11.4% Dec 31, 2018 10-K 2021-03-15
Q3 2018 $4M -$404K -9.18% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $4.36M +$90K +2.11% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $4.58M +$552K +13.7% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $4.46M +$485K +12.2% Dec 31, 2017 10-K 2020-03-16
Q3 2017 $4.4M +$191K +4.54% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $4.27M +$112K +2.69% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $4.03M -$290K -6.71% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $3.98M +$250K +6.71% Dec 31, 2016 10-K 2019-03-15
Q3 2016 $4.21M +$378K +9.86% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $4.16M +$374K +9.88% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $4.32M +$613K +16.5% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $3.73M -$741K -16.6% Dec 31, 2015 10-K 2018-03-14
Q3 2015 $3.83M -$817K -17.6% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 $3.79M +$3.51M +1252% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $3.71M Mar 31, 2015 10-Q 2015-05-14
Q4 2014 $4.47M +$4.19M +1495% Dec 31, 2014 10-K 2017-03-15
Q3 2014 $4.65M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $280K Jun 30, 2014 10-Q 2014-08-13
Q4 2013 $280K $0 0% Dec 31, 2013 10-K 2016-03-15
Q4 2012 $280K Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.